课题基金 / 基金详情

NSABP P-1--TRIAL TO DETERMINE WORTH OF TAMOXIFEN FOR PREVENTING BREAST CANCER

NSABP P-1--TRIAL TO DETERMINE WORTH OF TAMOXIFEN FOR PREVENTING BREAST CANCER
NSABP P-1——确定他莫昔芬预防乳腺癌价值的试验
批准号：
6275081
负责人：
STEPHEN BERNARD
金额：
$1.58万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275081
关键词：
breast neoplasms cancer prevention cancer risk chemoprevention clinical research clinical trials drug screening /evaluation female human mortality human subject human therapy evaluation longitudinal human study neoplasm /cancer chemotherapy tamoxifen

项目摘要

项目成果

STEPHEN BERNARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will determine whether long-term tamoxifen therapy is effective in preventing invasive breast cancer in women at increased risk for the disease and whether the mortality attributed to the disease is reduced by tamoxifen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSABP P-1--TRIAL TO DETERMINE WORTH OF TAMOXIFEN FOR PREVENTING BREAST CANCER
MX 405: INTRADOSE (CISPLATIN & EPINEPHRINE) INJECTABLE GEL
BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER
BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER
海外基金